All Posts
SMAB Emeritus Member Becomes Surgical Chair
The Cholangiocarcinoma Foundation is pleased to share that Dr. Cristina R. Ferrone, one of the Foundation's esteemed Science and Medical…
2024 Chicago Cholangiocarcinoma Symposium
The 2024 Chicago Cholangiocarcinoma Symposium is set to convene in Chicago, drawing together leading experts, researchers, healthcare professionals, patients, and…
GNS561-221-1
Study Name GNS561-221-1 ClinicalTrials.gov Identifier (if applicable) NCT05874414 Clinical Trial Category (check all that apply) Beyond First…
CCF Funding Part of Important Study and Publication
Nabeel M. Bardeesy, PhD is the John R. Gallagher III and Katherine A. Gallagher Endowed Chair in Gastrointestinal Cancer Research…
Cholangiocarcinoma SURVIVOR
By Kathi and Andrew Dyal Andrew and I attended the same high school in LaGrangeville, NY. We ran in the…
Celebrating Seven Years of CholangioConnect
A Vision Takes Shape In the complex and often isolating world of cholangiocarcinoma, the CholangioConnect program emerged seven years ago…
Hope and Gratitude, One Step at a Time
by Heather Black, with contributions from Joan and Johanna Memorial Day 2024 in Boulder, Colorado, was a perfect day of…
De's 0.9 Mile Marathon Celebrates Community
On Saturday, June 1st, 2024, the streets of Baltimore, Maryland, came alive with celebration and remembrance as the second annual…
A Phase Ia/Ib Study of the Combination of the FGFR inhibitor Pemigatinib and the EGFR inhibitor Afatinib in Advanced Refractory Solid Tumors
Study Name A Phase Ia/Ib Study of the Combination of the FGFR inhibitor Pemigatinib and the EGFR inhibitor Afatinib in Advanced Refractory Solid Tumors…
The 5th Annual Quack Out Cholangio 5k Run/Walk to Crush Bile Duct Cancer
The 5th Annual Quack Out Cholangio 5k Run/Walk to Crush Bile Duct Cancer was held May 18th at Midnight Oil…